Gene: PHTF1
Official Full Name: putative homeodomain transcription factor 1provided by HGNC
Gene Summary: Predicted to be located in cis-Golgi network membrane and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31574 | PHTF1 Knockout cell line (HeLa) | Human | PHTF1 | 1:3~1:6 | Negative | Online Inquiry |
KO31575 | PHTF1 Knockout cell line (HCT 116) | Human | PHTF1 | 1:2~1:4 | Negative | Online Inquiry |
KO31576 | PHTF1 Knockout cell line (HEK293) | Human | PHTF1 | 1:3~1:6 | Negative | Online Inquiry |
KO31577 | PHTF1 Knockout cell line (A549) | Human | PHTF1 | 1:3~1:4 | Negative | Online Inquiry |
PHTF1 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the PHTF1 gene, which is critical in various cellular processes, including transcription regulation and cell proliferation. By utilizing CRISPR/Cas9 technology, these cell lines allow researchers to study the impact of PHTF1 gene absence on cellular functions and disease mechanisms in a controlled environment.
The key function of PHTF1 Gene Knockout Cell Lines lies in their ability to mimic certain pathological conditions, thereby providing valuable insights into the role of the PHTF1 gene in gene expression regulation and cellular response to various stimuli. By creating a knockout scenario, scientists can explore alterations in signal transduction pathways, metabolic processes, and other molecular interactions that are otherwise obscured in wild-type counterparts. This facilitates a deeper understanding of diseases linked to PHTF1 dysregulation, including certain cancers and metabolic disorders.
The scientific importance of these knockout cell lines is underscored by their applications in both research and clinical settings; they represent powerful tools in drug development, therapeutic interventions, and biomarker discovery. Researchers can use these cell lines to screen for potential therapeutic compounds and validate drug targets, thus accelerating the pathway from bench to bedside. Furthermore, the use of PHTF1 knockout models can enhance translational research, leading to more effective and personalized treatment strategies.
Compared to alternatives such as transient transfection or RNA interference, which may yield transient effects or incomplete knockdown, PHTF1 Gene Knockout Cell Lines provide a stable and heritable gene modification, allowing for long-term studies and reproducibility. The robustness of this model ensures that experimental results are reliable and can be leveraged across multiple experiments, enhancing data consistency.
Given the pressing need for innovative research tools that drive scientific discovery, our PHTF1 Gene Knockout Cell Lines represent an invaluable asset for researchers and clinicians alike. Our company specializes in providing high-quality, reliable genetic products tailored to meet the dynamic needs of modern research, empowering the scientific community to push the boundaries of knowledge in disease treatment and prevention.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.